Cite

HARVARD Citation

    Chan, D. et al. (2022). Vigilance for carcinoid heart disease is still required in the era of somatostatin analogues: Lessons from a case series. Asia-Pacific journal of clinical oncology. 18 (3), pp. 209-216. [Online]. 
  
Back to record